thymopoietin-iii and Dysentery--Bacillary

thymopoietin-iii has been researched along with Dysentery--Bacillary* in 1 studies

Other Studies

1 other study(ies) available for thymopoietin-iii and Dysentery--Bacillary

Article	Year
[The treatment of protracted forms of Flexner dysentery]. Terapevticheskii arkhiv, 1991, Volume: 63, Issue:11 The clinical efficacy of sodium nucleinate (SN) combined with splenin and quercetin given for lingering Flexner's dysentery in a group of 43 patients was compared with that of routine therapy used in a group of the same number of patients. It has been established that the above drug combination favours the elimination of the pathological symptoms of dyspepsia, the arrest of bacterial isolation and normalization of the immune status. Provided the effect of the combined drug treatment is insufficient, the method of choice is the administration of gene engineering alpha 2-interferon (reaferon) in combination with tocopherol acetate and rectal suppositories containing methyluracil. Topics: Adjuvants, Immunologic; Adult; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Dysentery, Bacillary; Humans; Immunity, Cellular; Middle Aged; Nucleic Acids; Quercetin; RNA, Fungal; Shigella flexneri; Thymopoietins; Time Factors	1991

Article

Year

[The treatment of protracted forms of Flexner dysentery].

Terapevticheskii arkhiv, 1991, Volume: 63, Issue:11

The clinical efficacy of sodium nucleinate (SN) combined with splenin and quercetin given for lingering Flexner's dysentery in a group of 43 patients was compared with that of routine therapy used in a group of the same number of patients. It has been established that the above drug combination favours the elimination of the pathological symptoms of dyspepsia, the arrest of bacterial isolation and normalization of the immune status. Provided the effect of the combined drug treatment is insufficient, the method of choice is the administration of gene engineering alpha 2-interferon (reaferon) in combination with tocopherol acetate and rectal suppositories containing methyluracil.

Topics: Adjuvants, Immunologic; Adult; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Dysentery, Bacillary; Humans; Immunity, Cellular; Middle Aged; Nucleic Acids; Quercetin; RNA, Fungal; Shigella flexneri; Thymopoietins; Time Factors

1991